Navigation Links
Faulty proteins may prove significant in identifying new treatments for ovarian cancer
Date:1/13/2012

PORTLAND, Ore. -- A constellation of defective proteins suspected in causing a malfunction in the body's ability to repair its own DNA could be the link scientists need to prove a new class of drugs will be effective in treating a broad range of ovarian cancer patients, an Oregon Health & Science University Knight Cancer Institute study found.

These research results, published this week in PLoS ONE, have prompted additional exploration into whether the patient population included in clinical trials for drugs that target the enzyme poly ADP ribose polymerase (PARP) should be expanded. Several forms of cancer are more dependent on PARP for their growth than regular cells, which means that targeting these enzymes when they go haywire is a potentially effective way to treat ovarian cancer. Currently PARP inhibitors are being tested with patients who have two types of malfunctioning proteins, BRCA1 or BRCA2. But, the OHSU Knight Cancer Institute study of additional proteins, beyond BRCA proteins, suggests that they too are playing a role in driving ovarian cancer.

Tapping into the potential of PARP inhibitors could change the dynamics of ovarian cancer treatment. There has not been a substantial increase in treatment options for ovarian cancer in the past two decades, said Tanja Pejovic, M.D., Ph.D., gynecologic oncologist at the OHSU Knight Cancer Institute. Pejovic, who led the study of these additional defective proteins, added that the results provide evidence that further research into the role of multiple proteins is warranted.

Only about 10 to 15 percent of women with ovarian cancer have BRCA 1 or BRCA 2 mutations.

Pejovic's study of 186 patients with nonhereditary cancer found that 41 percent who had an early recurrence of the disease also had abnormal levels of the other proteins tracked. In contrast, only 19.5 percent of patients who hadn't yet had a recurrence of the disease in three years had abnormal levels of the
'/>"/>

Contact: Elisa Williams
willieli@ohsu.edu
503-494-8231
Oregon Health & Science University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Faulty molecular switch can cause infertility or miscarriage
2. Faulty gene linked to disorders of sexual development
3. Faulty clean-up process may be key event in Huntingtons disease
4. Penn scientists pioneer new method for watching proteins fold
5. Lets do the twist: Spiral proteins are efficient gene delivery agents
6. Control by the matrix: RUB researchers decipher the role of proteins in the cell environment
7. Cellular processing of proteins found in Congolese child birthing tea now revealed
8. Targeted antibacterial proteins may offer antibiotic alternative
9. New technique enables study of challenging proteins
10. So many proteins, so much promise
11. Exercise before and during early pregnancy increases two beneficial proteins for mothers-to-be
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... South Africa is entering what is described by the ... Season." The Eastern Cape provincial government warned residents ... of strong winds and veld fires. A high ... interior and along the coast in the Great Kei ... coastal regions, and during thunderstorms. The thunderstorms bring ...
(Date:8/27/2014)... number of consumers are willing to pay a premium ... whether they,re getting what the label claims is another ... devising a new way to make sure farms are ... ACS, Journal of Agricultural and Food Chemistry , ... the Bavarian Health and Food Safety Authority and the ...
(Date:8/27/2014)... have shown that excessive iron is closely ... Previous studies from Chunyan Guo and co-workers ... shown that baicalin prevented iron accumulation after ... 1 expression, and increased ferroportin 1 expression ... disease rats. However, the relationship between iron ...
Breaking Biology News(10 mins):
... oral drug therapy called fenobam has shown promising initial results ... patients with Fragile X syndrome (FXS). Findings of the ... Center and the University of California, Davis, Medical Center are ... Journal of Medical Genetics . Results ...
... Human Genome Center at Shanghai (South Center, hereafter) was ... in Shanghai. To commemorate this important event, ,which marks ... specially organize a series of mini-reviews for ,this special ... attention of the Chinese life science research workers ,to ...
... MADISON, WI, JANUARY 5, 2009 Currently, plant ... ecological risks from chemical pesticides to nontarget plants ... plants. Protection of the plant development and reproduction ... protection of animals. Past research conducted by the ...
Cached Biology News:Promising new drug being evaluated as possible treatment option for fragile X syndrome 2Human genomics in China 2Human genomics in China 3Human genomics in China 4Human genomics in China 5Human genomics in China 6Human genomics in China 7Human genomics in China 8Human genomics in China 9Human genomics in China 10Human genomics in China 11
(Date:8/27/2014)... , Aug. 27, 2014  A novel biomarker ... help physicians better identify early-stage disease, when treatment ... according to a new study in The Journal ... (NYSE: DGX ) and other institutions ... protein outperformed conventional antibody-serum testing, including rheumatoid factor ...
(Date:8/27/2014)... Westminster, CO (PRWEB) August 27, 2014 ... image analysis services to the pharmaceutical and medical ... and expansion. The fast growing company has consolidated ... in Aurora and Boulder to Westminster, CO, just north ... and Histology Lab, 7575 W. 103rd Ave., Suite 100, ...
(Date:8/27/2014)... JUNCTION, N.J. , Aug. 27, 2014 ... innovative drug delivery technologies, today announced that it has ... Jersey Business & Industry Association,s 2014 Awards for ... were selected by an independent panel of judges from ... company volunteers. Award winners will be honored at a ...
(Date:8/27/2014)... According to the 2013 Raw Material and ... and feel of markets for raw materials and ingredient ... push for more branded, science-backed products.” , Natural products ... growth in the last decade as consumers increasingly demand ... to fit a more ‘wellness’ lifestyle approach. Due ...
Breaking Biology Technology:Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 2Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 3Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 4Flagship Biosciences Announces Relocation and Expansion 2Tris Pharma Selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 3
... May 21, 2012  The Large Urology Group ... urologists, today discredited recommendations by the U.S. Preventive ... testing. USPSTF,s final recommendation, released today, ... the PSA test. This comes despite overwhelming opposition ...
... Biopharma, Inc. (OTC/BB: GNBP), a biotechnology company developing targeted ... to Shareholders to the Investors section of the Company,s ... 15, 2012, the Company filed with the U.S. Securities ... months ended March 31, 2012 on Form 10-Q.  The ...
... NEW YORK, May 18, 2012  Intellect Neurosciences, Inc. ... the company,s chairman and CEO, will be presenting ... Conference. (Logo:  http://photos.prnewswire.com/prnh/20111214/NY22484LOGO ) ... is "Prefibrillar Tau Neoepitopes Offer Attractive Targets for ...
Cached Biology Technology:Urologists Outraged over Government Panel's Recommendation to Stop Life-Saving Prostate Cancer Testing 2Urologists Outraged over Government Panel's Recommendation to Stop Life-Saving Prostate Cancer Testing 3Genesis Biopharma Issues Letter To Shareholders 2Genesis Biopharma Issues Letter To Shareholders 3Genesis Biopharma Issues Letter To Shareholders 4Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference 2Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference 3
This free-standing laminar flow hood provides a vertical flow of HEPA-filtered air to create a clean processing area. It includes a fluorescent light and motorized sliding shield. Options include wor...
... This CLS number is a ... easily match Cornings product number. ... please order under the old ... customer service for assistance. ID ...
... GyroTwister GX-1000 3-D Shaker , ... shaking motion of the GyroTwister GX-1000 is ... ideal for general mixing as well as ... speed is continuously adjustable across a broad ...
...
Biology Products: